nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—UGT1A6—NRF2 pathway—FGF13—pancreatic cancer	0.00207	0.151	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—NFE2L2—pancreatic cancer	0.00206	0.15	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	0.0015	0.109	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	0.00146	0.107	CbGpPWpGaD
Deferiprone—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00116	0.00117	CcSEcCtD
Deferiprone—Abdominal pain—Sunitinib—pancreatic cancer	0.00116	0.00117	CcSEcCtD
Deferiprone—Body temperature increased—Sunitinib—pancreatic cancer	0.00116	0.00117	CcSEcCtD
Deferiprone—Diarrhoea—Erlotinib—pancreatic cancer	0.00116	0.00117	CcSEcCtD
Deferiprone—Oedema peripheral—Docetaxel—pancreatic cancer	0.00115	0.00117	CcSEcCtD
Deferiprone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00115	0.00117	CcSEcCtD
Deferiprone—Connective tissue disorder—Docetaxel—pancreatic cancer	0.00115	0.00117	CcSEcCtD
Deferiprone—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00115	0.00117	CcSEcCtD
Deferiprone—Urethral disorder—Docetaxel—pancreatic cancer	0.00115	0.00116	CcSEcCtD
Deferiprone—Infection—Fluorouracil—pancreatic cancer	0.00115	0.00116	CcSEcCtD
Deferiprone—UGT1A6—Oxidative Stress—SOD2—pancreatic cancer	0.00114	0.0835	CbGpPWpGaD
Deferiprone—Osteoarthritis—Epirubicin—pancreatic cancer	0.00114	0.00116	CcSEcCtD
Deferiprone—Pain in extremity—Epirubicin—pancreatic cancer	0.00114	0.00116	CcSEcCtD
Deferiprone—Diplopia—Epirubicin—pancreatic cancer	0.00114	0.00116	CcSEcCtD
Deferiprone—Skin disorder—Gemcitabine—pancreatic cancer	0.00114	0.00116	CcSEcCtD
Deferiprone—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00113	0.00115	CcSEcCtD
Deferiprone—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00113	0.00115	CcSEcCtD
Deferiprone—Hypotension—Irinotecan—pancreatic cancer	0.00113	0.00114	CcSEcCtD
Deferiprone—Increased appetite—Doxorubicin—pancreatic cancer	0.00113	0.00114	CcSEcCtD
Deferiprone—Hypotension—Gemcitabine—pancreatic cancer	0.0011	0.00111	CcSEcCtD
Deferiprone—Eye disorder—Docetaxel—pancreatic cancer	0.0011	0.00111	CcSEcCtD
Deferiprone—Cardiac disorder—Docetaxel—pancreatic cancer	0.00109	0.0011	CcSEcCtD
Deferiprone—Vomiting—Tamoxifen—pancreatic cancer	0.00109	0.0011	CcSEcCtD
Deferiprone—Cardiac failure—Doxorubicin—pancreatic cancer	0.00108	0.0011	CcSEcCtD
Deferiprone—Hypotension—Fluorouracil—pancreatic cancer	0.00108	0.00109	CcSEcCtD
Deferiprone—Hypersensitivity—Sunitinib—pancreatic cancer	0.00108	0.00109	CcSEcCtD
Deferiprone—Rash—Tamoxifen—pancreatic cancer	0.00108	0.00109	CcSEcCtD
Deferiprone—Dermatitis—Tamoxifen—pancreatic cancer	0.00108	0.00109	CcSEcCtD
Deferiprone—Vomiting—Erlotinib—pancreatic cancer	0.00107	0.00109	CcSEcCtD
Deferiprone—Somnolence—Irinotecan—pancreatic cancer	0.00107	0.00109	CcSEcCtD
Deferiprone—Headache—Tamoxifen—pancreatic cancer	0.00107	0.00108	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00107	0.00108	CcSEcCtD
Deferiprone—Rash—Erlotinib—pancreatic cancer	0.00106	0.00108	CcSEcCtD
Deferiprone—Dermatitis—Erlotinib—pancreatic cancer	0.00106	0.00108	CcSEcCtD
Deferiprone—Angiopathy—Docetaxel—pancreatic cancer	0.00106	0.00108	CcSEcCtD
Deferiprone—Dehydration—Epirubicin—pancreatic cancer	0.00106	0.00108	CcSEcCtD
Deferiprone—Dyspepsia—Irinotecan—pancreatic cancer	0.00106	0.00107	CcSEcCtD
Deferiprone—Immune system disorder—Docetaxel—pancreatic cancer	0.00106	0.00107	CcSEcCtD
Deferiprone—Headache—Erlotinib—pancreatic cancer	0.00106	0.00107	CcSEcCtD
Deferiprone—Diplopia—Doxorubicin—pancreatic cancer	0.00106	0.00107	CcSEcCtD
Deferiprone—Osteoarthritis—Doxorubicin—pancreatic cancer	0.00106	0.00107	CcSEcCtD
Deferiprone—Pain in extremity—Doxorubicin—pancreatic cancer	0.00106	0.00107	CcSEcCtD
Deferiprone—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00106	0.00107	CcSEcCtD
Deferiprone—Chills—Docetaxel—pancreatic cancer	0.00105	0.00107	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00105	0.00107	CcSEcCtD
Deferiprone—Asthenia—Sunitinib—pancreatic cancer	0.00105	0.00106	CcSEcCtD
Deferiprone—Decreased appetite—Irinotecan—pancreatic cancer	0.00105	0.00106	CcSEcCtD
Deferiprone—Somnolence—Gemcitabine—pancreatic cancer	0.00104	0.00106	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00104	0.00105	CcSEcCtD
Deferiprone—Fatigue—Irinotecan—pancreatic cancer	0.00104	0.00105	CcSEcCtD
Deferiprone—Pruritus—Sunitinib—pancreatic cancer	0.00103	0.00105	CcSEcCtD
Deferiprone—Pain—Irinotecan—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Deferiprone—Mental disorder—Docetaxel—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Deferiprone—Somnolence—Fluorouracil—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Deferiprone—Malnutrition—Docetaxel—pancreatic cancer	0.00102	0.00103	CcSEcCtD
Deferiprone—Decreased appetite—Gemcitabine—pancreatic cancer	0.00102	0.00103	CcSEcCtD
Deferiprone—Dyspepsia—Fluorouracil—pancreatic cancer	0.00102	0.00103	CcSEcCtD
Deferiprone—Nausea—Tamoxifen—pancreatic cancer	0.00101	0.00103	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00101	0.00103	CcSEcCtD
Deferiprone—Fatigue—Gemcitabine—pancreatic cancer	0.00101	0.00103	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00101	0.00102	CcSEcCtD
Deferiprone—Pain—Gemcitabine—pancreatic cancer	0.001	0.00102	CcSEcCtD
Deferiprone—Nausea—Erlotinib—pancreatic cancer	0.001	0.00102	CcSEcCtD
Deferiprone—Decreased appetite—Fluorouracil—pancreatic cancer	0.001	0.00102	CcSEcCtD
Deferiprone—Diarrhoea—Sunitinib—pancreatic cancer	0.001	0.00101	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000996	0.00101	CcSEcCtD
Deferiprone—Back pain—Docetaxel—pancreatic cancer	0.000987	0.001	CcSEcCtD
Deferiprone—Pain—Fluorouracil—pancreatic cancer	0.000986	0.001	CcSEcCtD
Deferiprone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000985	0.000999	CcSEcCtD
Deferiprone—Dehydration—Doxorubicin—pancreatic cancer	0.000983	0.000997	CcSEcCtD
Deferiprone—Pancreatitis—Epirubicin—pancreatic cancer	0.000968	0.000982	CcSEcCtD
Deferiprone—Body temperature increased—Irinotecan—pancreatic cancer	0.000952	0.000965	CcSEcCtD
Deferiprone—Abdominal pain—Irinotecan—pancreatic cancer	0.000952	0.000965	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000952	0.000965	CcSEcCtD
Deferiprone—Pancytopenia—Epirubicin—pancreatic cancer	0.000938	0.000951	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000932	0.000945	CcSEcCtD
Deferiprone—Vomiting—Sunitinib—pancreatic cancer	0.00093	0.000943	CcSEcCtD
Deferiprone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000927	0.00094	CcSEcCtD
Deferiprone—Neutropenia—Epirubicin—pancreatic cancer	0.000923	0.000936	CcSEcCtD
Deferiprone—Rash—Sunitinib—pancreatic cancer	0.000922	0.000935	CcSEcCtD
Deferiprone—Dermatitis—Sunitinib—pancreatic cancer	0.000921	0.000934	CcSEcCtD
Deferiprone—Urticaria—Fluorouracil—pancreatic cancer	0.000916	0.000929	CcSEcCtD
Deferiprone—Headache—Sunitinib—pancreatic cancer	0.000916	0.000929	CcSEcCtD
Deferiprone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000912	0.000925	CcSEcCtD
Deferiprone—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000901	0.000914	CcSEcCtD
Deferiprone—Weight increased—Epirubicin—pancreatic cancer	0.000899	0.000911	CcSEcCtD
Deferiprone—Pancreatitis—Doxorubicin—pancreatic cancer	0.000896	0.000908	CcSEcCtD
Deferiprone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000887	0.0009	CcSEcCtD
Deferiprone—Pneumonia—Epirubicin—pancreatic cancer	0.000886	0.000898	CcSEcCtD
Deferiprone—Convulsion—Docetaxel—pancreatic cancer	0.000884	0.000896	CcSEcCtD
Deferiprone—Hypertension—Docetaxel—pancreatic cancer	0.000881	0.000893	CcSEcCtD
Deferiprone—Infestation NOS—Epirubicin—pancreatic cancer	0.000881	0.000893	CcSEcCtD
Deferiprone—Infestation—Epirubicin—pancreatic cancer	0.000881	0.000893	CcSEcCtD
Deferiprone—Arthralgia—Docetaxel—pancreatic cancer	0.000869	0.000881	CcSEcCtD
Deferiprone—Nausea—Sunitinib—pancreatic cancer	0.000869	0.000881	CcSEcCtD
Deferiprone—Pancytopenia—Doxorubicin—pancreatic cancer	0.000868	0.00088	CcSEcCtD
Deferiprone—Asthenia—Irinotecan—pancreatic cancer	0.000864	0.000876	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000863	0.000875	CcSEcCtD
Deferiprone—Jaundice—Epirubicin—pancreatic cancer	0.000858	0.00087	CcSEcCtD
Deferiprone—Neutropenia—Doxorubicin—pancreatic cancer	0.000854	0.000866	CcSEcCtD
Deferiprone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00085	0.000862	CcSEcCtD
Deferiprone—Asthenia—Gemcitabine—pancreatic cancer	0.000842	0.000853	CcSEcCtD
Deferiprone—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000834	0.000846	CcSEcCtD
Deferiprone—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000833	0.000844	CcSEcCtD
Deferiprone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000833	0.000844	CcSEcCtD
Deferiprone—Weight increased—Doxorubicin—pancreatic cancer	0.000832	0.000843	CcSEcCtD
Deferiprone—Epistaxis—Epirubicin—pancreatic cancer	0.000831	0.000842	CcSEcCtD
Deferiprone—Pruritus—Gemcitabine—pancreatic cancer	0.00083	0.000842	CcSEcCtD
Deferiprone—Infection—Docetaxel—pancreatic cancer	0.000827	0.000839	CcSEcCtD
Deferiprone—Diarrhoea—Irinotecan—pancreatic cancer	0.000824	0.000836	CcSEcCtD
Deferiprone—Agranulocytosis—Epirubicin—pancreatic cancer	0.000822	0.000833	CcSEcCtD
Deferiprone—Pneumonia—Doxorubicin—pancreatic cancer	0.000819	0.000831	CcSEcCtD
Deferiprone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000817	0.000828	CcSEcCtD
Deferiprone—Pruritus—Fluorouracil—pancreatic cancer	0.000816	0.000827	CcSEcCtD
Deferiprone—Infestation NOS—Doxorubicin—pancreatic cancer	0.000815	0.000826	CcSEcCtD
Deferiprone—Infestation—Doxorubicin—pancreatic cancer	0.000815	0.000826	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	0.000814	0.0594	CbGpPWpGaD
Deferiprone—Skin disorder—Docetaxel—pancreatic cancer	0.000809	0.00082	CcSEcCtD
Deferiprone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000803	0.000814	CcSEcCtD
Deferiprone—Jaundice—Doxorubicin—pancreatic cancer	0.000794	0.000805	CcSEcCtD
Deferiprone—Hepatitis—Epirubicin—pancreatic cancer	0.00079	0.000801	CcSEcCtD
Deferiprone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000789	0.0008	CcSEcCtD
Deferiprone—Pharyngitis—Epirubicin—pancreatic cancer	0.000785	0.000795	CcSEcCtD
Deferiprone—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000781	0.000791	CcSEcCtD
Deferiprone—Oedema peripheral—Epirubicin—pancreatic cancer	0.000779	0.000789	CcSEcCtD
Deferiprone—Hypotension—Docetaxel—pancreatic cancer	0.000778	0.000789	CcSEcCtD
Deferiprone—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000777	0.000788	CcSEcCtD
Deferiprone—Urethral disorder—Epirubicin—pancreatic cancer	0.000775	0.000786	CcSEcCtD
Deferiprone—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000771	0.000781	CcSEcCtD
Deferiprone—Epistaxis—Doxorubicin—pancreatic cancer	0.000768	0.000779	CcSEcCtD
Deferiprone—Vomiting—Irinotecan—pancreatic cancer	0.000766	0.000776	CcSEcCtD
Deferiprone—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00076	0.000771	CcSEcCtD
Deferiprone—Rash—Irinotecan—pancreatic cancer	0.000759	0.00077	CcSEcCtD
Deferiprone—Dermatitis—Irinotecan—pancreatic cancer	0.000759	0.000769	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000759	0.000769	CcSEcCtD
Deferiprone—Headache—Irinotecan—pancreatic cancer	0.000755	0.000765	CcSEcCtD
Deferiprone—Vomiting—Gemcitabine—pancreatic cancer	0.000746	0.000756	CcSEcCtD
Deferiprone—Somnolence—Docetaxel—pancreatic cancer	0.00074	0.00075	CcSEcCtD
Deferiprone—Rash—Gemcitabine—pancreatic cancer	0.00074	0.00075	CcSEcCtD
Deferiprone—Dermatitis—Gemcitabine—pancreatic cancer	0.000739	0.000749	CcSEcCtD
Deferiprone—Eye disorder—Epirubicin—pancreatic cancer	0.000739	0.000749	CcSEcCtD
Deferiprone—Headache—Gemcitabine—pancreatic cancer	0.000735	0.000745	CcSEcCtD
Deferiprone—Cardiac disorder—Epirubicin—pancreatic cancer	0.000734	0.000744	CcSEcCtD
Deferiprone—Vomiting—Fluorouracil—pancreatic cancer	0.000733	0.000744	CcSEcCtD
Deferiprone—Dyspepsia—Docetaxel—pancreatic cancer	0.000733	0.000743	CcSEcCtD
Deferiprone—Hepatitis—Doxorubicin—pancreatic cancer	0.000731	0.000742	CcSEcCtD
Deferiprone—Rash—Fluorouracil—pancreatic cancer	0.000727	0.000737	CcSEcCtD
Deferiprone—Dermatitis—Fluorouracil—pancreatic cancer	0.000727	0.000737	CcSEcCtD
Deferiprone—Pharyngitis—Doxorubicin—pancreatic cancer	0.000726	0.000736	CcSEcCtD
Deferiprone—Decreased appetite—Docetaxel—pancreatic cancer	0.000724	0.000734	CcSEcCtD
Deferiprone—Headache—Fluorouracil—pancreatic cancer	0.000723	0.000733	CcSEcCtD
Deferiprone—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000722	0.000732	CcSEcCtD
Deferiprone—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00072	0.00073	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000719	0.000729	CcSEcCtD
Deferiprone—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000719	0.000729	CcSEcCtD
Deferiprone—Fatigue—Docetaxel—pancreatic cancer	0.000718	0.000728	CcSEcCtD
Deferiprone—Angiopathy—Epirubicin—pancreatic cancer	0.000717	0.000727	CcSEcCtD
Deferiprone—Urethral disorder—Doxorubicin—pancreatic cancer	0.000717	0.000727	CcSEcCtD
Deferiprone—Nausea—Irinotecan—pancreatic cancer	0.000715	0.000725	CcSEcCtD
Deferiprone—Immune system disorder—Epirubicin—pancreatic cancer	0.000714	0.000724	CcSEcCtD
Deferiprone—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000712	0.000722	CcSEcCtD
Deferiprone—Pain—Docetaxel—pancreatic cancer	0.000712	0.000722	CcSEcCtD
Deferiprone—Chills—Epirubicin—pancreatic cancer	0.000709	0.000719	CcSEcCtD
Deferiprone—Nausea—Gemcitabine—pancreatic cancer	0.000697	0.000707	CcSEcCtD
Deferiprone—Mental disorder—Epirubicin—pancreatic cancer	0.000693	0.000702	CcSEcCtD
Deferiprone—Malnutrition—Epirubicin—pancreatic cancer	0.000688	0.000698	CcSEcCtD
Deferiprone—Nausea—Fluorouracil—pancreatic cancer	0.000685	0.000695	CcSEcCtD
Deferiprone—Eye disorder—Doxorubicin—pancreatic cancer	0.000683	0.000693	CcSEcCtD
Deferiprone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000681	0.00069	CcSEcCtD
Deferiprone—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000679	0.000688	CcSEcCtD
Deferiprone—Back pain—Epirubicin—pancreatic cancer	0.000666	0.000675	CcSEcCtD
Deferiprone—Angiopathy—Doxorubicin—pancreatic cancer	0.000664	0.000673	CcSEcCtD
Deferiprone—Immune system disorder—Doxorubicin—pancreatic cancer	0.000661	0.00067	CcSEcCtD
Deferiprone—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000659	0.000668	CcSEcCtD
Deferiprone—Abdominal pain—Docetaxel—pancreatic cancer	0.000658	0.000667	CcSEcCtD
Deferiprone—Body temperature increased—Docetaxel—pancreatic cancer	0.000658	0.000667	CcSEcCtD
Deferiprone—Chills—Doxorubicin—pancreatic cancer	0.000656	0.000665	CcSEcCtD
Deferiprone—Mental disorder—Doxorubicin—pancreatic cancer	0.000641	0.00065	CcSEcCtD
Deferiprone—Malnutrition—Doxorubicin—pancreatic cancer	0.000637	0.000646	CcSEcCtD
Deferiprone—Back pain—Doxorubicin—pancreatic cancer	0.000616	0.000624	CcSEcCtD
Deferiprone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000613	0.000622	CcSEcCtD
Deferiprone—Asthenia—Docetaxel—pancreatic cancer	0.000597	0.000606	CcSEcCtD
Deferiprone—Convulsion—Epirubicin—pancreatic cancer	0.000596	0.000604	CcSEcCtD
Deferiprone—Hypertension—Epirubicin—pancreatic cancer	0.000594	0.000602	CcSEcCtD
Deferiprone—Pruritus—Docetaxel—pancreatic cancer	0.000589	0.000597	CcSEcCtD
Deferiprone—Arthralgia—Epirubicin—pancreatic cancer	0.000586	0.000594	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000582	0.00059	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—NFE2L2—pancreatic cancer	0.00058	0.0423	CbGpPWpGaD
Deferiprone—Discomfort—Epirubicin—pancreatic cancer	0.000579	0.000587	CcSEcCtD
Deferiprone—Diarrhoea—Docetaxel—pancreatic cancer	0.00057	0.000578	CcSEcCtD
Deferiprone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000562	0.000569	CcSEcCtD
Deferiprone—Infection—Epirubicin—pancreatic cancer	0.000558	0.000566	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—TGFA—pancreatic cancer	0.000553	0.0404	CbGpPWpGaD
Deferiprone—Convulsion—Doxorubicin—pancreatic cancer	0.000552	0.000559	CcSEcCtD
Deferiprone—Nervous system disorder—Epirubicin—pancreatic cancer	0.000551	0.000558	CcSEcCtD
Deferiprone—Hypertension—Doxorubicin—pancreatic cancer	0.00055	0.000557	CcSEcCtD
Deferiprone—Skin disorder—Epirubicin—pancreatic cancer	0.000545	0.000553	CcSEcCtD
Deferiprone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000543	0.00055	CcSEcCtD
Deferiprone—Arthralgia—Doxorubicin—pancreatic cancer	0.000542	0.00055	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—SLC2A2—pancreatic cancer	0.000541	0.0395	CbGpPWpGaD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000538	0.000546	CcSEcCtD
Deferiprone—Discomfort—Doxorubicin—pancreatic cancer	0.000536	0.000543	CcSEcCtD
Deferiprone—Vomiting—Docetaxel—pancreatic cancer	0.000529	0.000537	CcSEcCtD
Deferiprone—Rash—Docetaxel—pancreatic cancer	0.000525	0.000532	CcSEcCtD
Deferiprone—Hypotension—Epirubicin—pancreatic cancer	0.000525	0.000532	CcSEcCtD
Deferiprone—Dermatitis—Docetaxel—pancreatic cancer	0.000524	0.000532	CcSEcCtD
Deferiprone—Headache—Docetaxel—pancreatic cancer	0.000522	0.000529	CcSEcCtD
Deferiprone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00052	0.000527	CcSEcCtD
Deferiprone—Infection—Doxorubicin—pancreatic cancer	0.000516	0.000523	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000512	0.000519	CcSEcCtD
Deferiprone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00051	0.000517	CcSEcCtD
Deferiprone—Skin disorder—Doxorubicin—pancreatic cancer	0.000505	0.000512	CcSEcCtD
Deferiprone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000502	0.000509	CcSEcCtD
Deferiprone—Somnolence—Epirubicin—pancreatic cancer	0.000499	0.000506	CcSEcCtD
Deferiprone—Nausea—Docetaxel—pancreatic cancer	0.000495	0.000501	CcSEcCtD
Deferiprone—Dyspepsia—Epirubicin—pancreatic cancer	0.000494	0.000501	CcSEcCtD
Deferiprone—Decreased appetite—Epirubicin—pancreatic cancer	0.000488	0.000495	CcSEcCtD
Deferiprone—Hypotension—Doxorubicin—pancreatic cancer	0.000486	0.000492	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000485	0.000492	CcSEcCtD
Deferiprone—Fatigue—Epirubicin—pancreatic cancer	0.000484	0.000491	CcSEcCtD
Deferiprone—Pain—Epirubicin—pancreatic cancer	0.00048	0.000487	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000473	0.00048	CcSEcCtD
Deferiprone—Somnolence—Doxorubicin—pancreatic cancer	0.000462	0.000468	CcSEcCtD
Deferiprone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000459	0.000466	CcSEcCtD
Deferiprone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000457	0.000464	CcSEcCtD
Deferiprone—Decreased appetite—Doxorubicin—pancreatic cancer	0.000452	0.000458	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000449	0.000455	CcSEcCtD
Deferiprone—Fatigue—Doxorubicin—pancreatic cancer	0.000448	0.000454	CcSEcCtD
Deferiprone—Urticaria—Epirubicin—pancreatic cancer	0.000446	0.000452	CcSEcCtD
Deferiprone—Pain—Doxorubicin—pancreatic cancer	0.000444	0.000451	CcSEcCtD
Deferiprone—Abdominal pain—Epirubicin—pancreatic cancer	0.000444	0.00045	CcSEcCtD
Deferiprone—Body temperature increased—Epirubicin—pancreatic cancer	0.000444	0.00045	CcSEcCtD
Deferiprone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000425	0.000431	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—HSPA1A—pancreatic cancer	0.000416	0.0304	CbGpPWpGaD
Deferiprone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000414	0.000419	CcSEcCtD
Deferiprone—Urticaria—Doxorubicin—pancreatic cancer	0.000413	0.000419	CcSEcCtD
Deferiprone—Body temperature increased—Doxorubicin—pancreatic cancer	0.000411	0.000416	CcSEcCtD
Deferiprone—Abdominal pain—Doxorubicin—pancreatic cancer	0.000411	0.000416	CcSEcCtD
Deferiprone—Asthenia—Epirubicin—pancreatic cancer	0.000403	0.000409	CcSEcCtD
Deferiprone—Pruritus—Epirubicin—pancreatic cancer	0.000397	0.000403	CcSEcCtD
Deferiprone—Diarrhoea—Epirubicin—pancreatic cancer	0.000384	0.00039	CcSEcCtD
Deferiprone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000383	0.000388	CcSEcCtD
Deferiprone—Asthenia—Doxorubicin—pancreatic cancer	0.000373	0.000378	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	0.000369	0.0269	CbGpPWpGaD
Deferiprone—Pruritus—Doxorubicin—pancreatic cancer	0.000368	0.000373	CcSEcCtD
Deferiprone—Vomiting—Epirubicin—pancreatic cancer	0.000357	0.000362	CcSEcCtD
Deferiprone—Diarrhoea—Doxorubicin—pancreatic cancer	0.000356	0.00036	CcSEcCtD
Deferiprone—Rash—Epirubicin—pancreatic cancer	0.000354	0.000359	CcSEcCtD
Deferiprone—Dermatitis—Epirubicin—pancreatic cancer	0.000354	0.000359	CcSEcCtD
Deferiprone—Headache—Epirubicin—pancreatic cancer	0.000352	0.000357	CcSEcCtD
Deferiprone—Nausea—Epirubicin—pancreatic cancer	0.000334	0.000338	CcSEcCtD
Deferiprone—Vomiting—Doxorubicin—pancreatic cancer	0.00033	0.000335	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	0.00033	0.0241	CbGpPWpGaD
Deferiprone—Rash—Doxorubicin—pancreatic cancer	0.000328	0.000332	CcSEcCtD
Deferiprone—Dermatitis—Doxorubicin—pancreatic cancer	0.000327	0.000332	CcSEcCtD
Deferiprone—Headache—Doxorubicin—pancreatic cancer	0.000326	0.00033	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	0.000323	0.0236	CbGpPWpGaD
Deferiprone—Nausea—Doxorubicin—pancreatic cancer	0.000309	0.000313	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	0.000308	0.0225	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PRSS1—pancreatic cancer	0.000142	0.0104	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—TGFB1—pancreatic cancer	0.000131	0.00956	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ARG2—pancreatic cancer	0.000123	0.00901	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—TYMP—pancreatic cancer	0.000108	0.00788	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GLP1R—pancreatic cancer	8.69e-05	0.00635	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—DPYD—pancreatic cancer	8.55e-05	0.00625	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SLC2A2—pancreatic cancer	8.12e-05	0.00593	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CD44—pancreatic cancer	6.29e-05	0.00459	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GCG—pancreatic cancer	6.03e-05	0.0044	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—STK11—pancreatic cancer	5.67e-05	0.00414	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—TYMS—pancreatic cancer	4.87e-05	0.00356	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—APOE—pancreatic cancer	3.96e-05	0.00289	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CG—pancreatic cancer	3.58e-05	0.00261	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PPARG—pancreatic cancer	3.45e-05	0.00252	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CD—pancreatic cancer	3.14e-05	0.0023	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CB—pancreatic cancer	2.74e-05	0.002	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTGS2—pancreatic cancer	2.72e-05	0.00198	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTEN—pancreatic cancer	2.37e-05	0.00173	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CA—pancreatic cancer	1.67e-05	0.00122	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—AKT1—pancreatic cancer	1.37e-05	0.000997	CbGpPWpGaD
